Last reviewed · How we verify

Providencia Urinary Tract Infection — Treatment Landscape & Competitive Intelligence

Providencia Urinary Tract Infection (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Providencia Urinary Tract Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Cipro ciprofloxacin Bayer AG Fluoroquinolone antibiotic DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A 1987-10-22
Claforan CEFOTAXIME Sterimax Cephalosporin Antibacterial 1981-01-01
Ofloxacine Ofloxacine Assistance Publique - Hôpitaux de Paris Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1
Ciprofloxacine Ciprofloxacine Poitiers University Hospital DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 6 drugs in Providencia Urinary Tract Infection
  2. Assistance Publique - Hôpitaux de Paris · 1 drug in Providencia Urinary Tract Infection
  3. Bayer AG · 1 drug in Providencia Urinary Tract Infection
  4. Poitiers University Hospital · 1 drug in Providencia Urinary Tract Infection
  5. Sterimax · 1 drug in Providencia Urinary Tract Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Providencia Urinary Tract Infection:

Cite this brief

Drug Landscape (2026). Providencia Urinary Tract Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/providencia-urinary-tract-infection. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing